Healthcare Professionals
HMS Plus
Hemostasis Management System
Du har precis klickat på en länk som tar dig till en annan webbplats. Om du fortsätter kommer du att lämna denna webbplats och gå till en webbplats som drivs av någon annan.
Medtronic Sverige varken granskar eller kontrollerar innehållet på den andra webbplatsen och tar inget ansvar för eventuella affärstransaktioner som du utför där. Din användning av den andra webbplatsen är föremål för användarvillkoren och sekretesspolicyn på den webbplatsen.
Det är möjligt att vissa produkter på den andra platsen inte är godkända i Sverige.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Välkommen till vår information för hälso- och sjukvårdspersonal.
Här hittar du produktinformation och annan info framtagen för dig som arbetar inom vården.
Arbetar du inom ett vårdyrke?
Healthcare Professionals
HMS Plus
Hemostasis Management System
When Measuring the ACT is Not Enough
Medtronic Perfusion Systems remains the pioneer and leader providing both a heparin dose response test and the only point of care heparin assay for individualized heparin and protamine management. Our technology has been identified as a required technology per the 2007 Society of Thoracic Surgeons (STS) guidelines5. The HMS Plus Hemostasis Management System is a reliable, versatile and effective platform for accurate heparin and protamine management1 resulting in lower procedural and operational costs2, 3, 4
The HMS Plus Hemostasis Management System is a reliable and versatile platform used to perform multiple tests for heparin management. By providing information regarding the individual patient's response to heparin, the HMS Plus System determines the appropriate dose for the patient so that the needed anticoagulant and antithrombotic effect can be achieved.
As part of Medtronic's ongoing commitment to helping you manage your work efficiently and effectively, we offer the HMS Plus EDM, an external data manager to accompany the HMS Plus Hemostasis Management System. By combining this powerful software with the HMS Plus System, you will have access to the reports you'll need to analyze and make informed decisions. This timesaving data management solution offers added convenience, reassurance and confidence – allowing you to stay focused on improving patient outcomes.
The HMS Plus EDM is a versatile Microsoft Access-based data management software application that runs on a PC and is designed to help you manage your patient and QC testing data. All aspects of Microsoft Access software required to run the application are included with the HMS Plus EDM.
Users can select from a list of pre-formatted reports to view the desired information using a variety of sort options.
HMS Plus System | ||
---|---|---|
Order Number | Description | # of Units |
30514 | HMS Plus System is a microprocessor-controlled instrument used to perform multiple tests for anticoagulation management. In addition to activated clotting time (ACT) tests, it allows the user to perform tests to measure actual circulating heparin concentration and assess a patient’s individual response to heparin. | 1 per box |
HMS Plus Cartridges - Each box contains 9 syringes, 9 blunt needles | ||
4 Channel | ||
304-01POR | Red - 0.0-0.9 mg/kg | 9 per box |
304-02POR | Yellow - 0.0-1.5 mg/kg | 9 per box |
304-03POR | Tan- 1.5-3.0 mg/kg | 9 per box |
304-04POR | Silver - 2.0-3.5 mg/kg | 9 per box |
304-05POR | Blue - 2.5-4.0 mg/kg | 9 per box |
304-06POR | Green - 3.5-5.0 mg/kg | 9 per box |
304-10POR | Purple - 4.5-6.0 mg/kg | 9 per box |
6 Channel | ||
304-07POR | Orange - 0.0-2.5 mg/kg | 9 per box |
304-08POR | Gold - 1.5-4.0 mg/kg | 9 per box |
304-09POR | White - 2.5-5.0 mg/kg | 9 per box |
304-11POR | Black - 3.5-6.0 mg/kg | 9 per box |
304-20POR | Heparin Dose Response (HDR) - 6-Channel | 9 per box |
304-30 | High Range ACT (HR-ACT) - 2-Channel | 9 per box |
HMS Plus Coagulation Controls | ||
Heparin Assay Controls, 10 vials controls, 10 vials deionized water per box | ||
306-01POR | Red/Yellow | 10 per box |
306-02POR | Tan/Silver | 10 per box |
306-03POR | Blue/Gold | 10 per box |
306-04POR | Green/White | 10 per box |
306-05POR | Orange | 10 per box |
306-09POR | Purple/Black | 10 per box |
HMS Plus CLOTtrac® Coagulation Controls | ||
Each box contains 15 vials of single-use control and 15 vials deionized water for reconstitution | ||
550-07 | CLOTtrac® HR Coagulation Control - Verify performance of HMS Plus HRACT Cartridges (304-30) and the HMS Plus | 15 per box |
550-08 | CLOTtrac® HR Abnormal Coagulation Control - Verify performance of HMS Plus HRACT cartridges (304-30) and the HMS Plus | 15 per box |
550-13 | CLOTtrac® HR Control Pack (contains both normal and abnormal controls) | 15 per box |
HMS Plus Accessories | ||
HMSPLUSSC | Bar Code Scanner | 1 per box |
300-01 | Monoject® Syringes, 3cc | 100 per box |
300-02 | Blunt Needles, 1-7/16", 19 GA | 100 per box |
313-51 | HEPtrac® Electronic Control for HMS Plus | 1 per box |
300-04 | Thermal Printer Paper | 5 rolls per box |
300-10 | Temperature Verification Cartridge for the HMS Plus | 1 per box |
300-19 | HMS Plus Cleaning Kit | 1 per box |
30032 | HMS Plus Cart | 1 per box |
31506 | HMS Plus Salvage Reservoir Cups | 100 per box |
313-50 | HEPline Kit | 1 per box |
HMSPLUSEDM | HMS Plus External Data Manager Software | 1 per box |
Despotis, GJ, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. J Thorac Cardiovascular Surg. 1995;110:46-54.
Hill, AG, et al. More precise heparin and protamine management during cardiopulmonary bypass. Proceedings of the American Academy of Cardiovascular Perfusion. 1990;12-16.
Despotis, GJ, et al. More effective suppression of hemostasis system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost. 1996;67:2-8.
Bowie, JE, et al. Automated management of heparin anticoagulation in cardiovascular surgery. Proceedings of the American Academy of Cardiovascular Perfusion. 1985;6:1-5